Table 1 |
|||||||
|
Reproducibility data provided by the manufacturer at various concentration levels |
|||||||
| Intraassay precision1,2,3 |
Interassay precision1,2,3 |
||||||
|
|
|||||||
| Mean Concentration (ng/ml) |
SD |
CV |
Mean Concentration (ng/ml) |
SD |
CV |
||
|
|
|||||||
| 1 |
1.5 |
0.08 |
5.3% |
1 |
3.9 |
0.26 |
6.7 |
| 2 |
3.0 |
0.14 |
4.7% |
2 |
15 |
0.84 |
5.6 |
| 3 |
13 |
0.47 |
3.6% |
3 |
60 |
3.2 |
5.3 |
| 4 |
56 |
2.4 |
4.3% |
4 |
371 |
22 |
5.9 |
| 5 |
316 |
18 |
5.7% |
||||
|
1. Beard DB, Haskell CM: Carcinoembryonic antigen in breast cancer. Am J Med 1986 Feb:80:241–245. 2. Begent R: The value of carcinoembryonic antigen measurement in clinical practice. Ann Clin Biochem 1984;21: 231–238. 3. 3. Begent R, Ruslin GJS: Tumour markers: from carcinoembryonic antigen to products of hybridoma technology. Cancer Surv 1989:8(1):107–121. (Source: manufacturer technical booklet. See SIEMENS in references list) | |||||||
Sajid et al. Harm Reduction Journal 2008 5:19 doi:10.1186/1477-7517-5-19 |
|||||||